On May 12, market capital recently focused on some penny-priced pharmaceutical stocks, and related individual stocks plummeted this afternoon. As of press release,$Emerging Pharmaceuticals (06108.HK) $Decreased 68.6% to HK$0.275, with a turnover of HK$268 million;$Tailin Pharmaceuticals (01011.HK) $It fell 18.67% to HK$0.183, with a turnover of HK$41,248,500.

Zhitong Finance previously pointed out in “10 Days Surge 600%, Everything Starts with the Resumption of Trading of Emerging Pharmaceuticals (06108)” that the sharp rise in emerging pharmaceuticals was mainly due to factors such as a sharp increase in the company's performance and getting rid of the negative impact of the takeover case a few years ago. However, from a fundamental point of view, the future prospects of the pharmaceutical distributor industry are not optimistic, and there is limited room for growth.